KRAS and familial pancreatic carcinoma: ATR stimulating CHK1 activation protects oncogenic K-Ras-expressing pancreatic cancer cells from DNA damage induced by the irradiation mimic neocarzinostatin [44], potentially through interference with G2 arrest and successful DSB repair.